Northrop Grumman is the most strategically irreplaceable U.S. defense prime, with sole-source positions on the B-21 Raider stealth bomber and Sentinel ICBM — two generational nuclear modernization programs that provide multi-decade revenue visibility. A record $95.7B backlog (2.3x annual revenue) and mid-single-digit revenue growth guidance for 2026 ($43.5-44.0B) underpin a stable compounder thesis, while $1.1B in annual IR&D investment and expanding international sales (18% YoY growth) create optionality. The primary risk is Sentinel cost overruns (Nunn-McCurdy breach in 2024, restructuring ongoing), but DoD certification for continuation and prototype silo groundbreaking in March 2026 confirm the program is advancing, not cancelling.
| Scenario | Prob. | Target | Driver |
|---|---|---|---|
| Bull | 25% | $850.00 | FY2026 revenue exceeds $44B high end of guidance — B-21 production ramp accelerates |
| Base | 50% | $744.00 | FY2026 revenue in $43.5-44.0B guided range — mid-single-digit growth continues |
| Bear | 25% | $520.00 | Defense budget flat or declining under sequestration / DOGE-driven cuts — FY2027 topline misses |
Auto-dispatched from (pm-router→pm-audit AGREE-both)
Initial /complete-research Phase A
Phase B — competitive deep dive + investment memo
Positioning skews toward near-term upside